The Latest News
FDA Issues Emergency Use Authorization for Impella RP as Therapy for COVID-19 Patients With Right Heart Failure
June 1, 2020—Abiomed announced that the FDA has issued an emergency use authorization (EUA) for the company’s Impella RP to include patients with COVID-19–related right heart failure or decompensation, including pulmonary embolism (PE).
FDA Approves AstraZeneca’s Brilinta to Reduce the Risk of a First Heart Attack or Stroke in High-Risk Patients With CAD
June 1, 2020—AstraZeneca announced FDA approval for Brilinta (ticagrelor) to reduce the risk of a first heart attack or stroke in high-risk patients with coronary artery disease (CAD).
Analysis of LEADERS FREE Supports Similar PCI Treatment in Women as in Men With High Bleeding Risk
May 29, 2020—The American College of Cardiology announced a recently published study that demonstrated that women with high bleeding risk should not be denied the benefits of percutaneous coronary intervention (PCI) when indicated and that bleeding avoidance strategies should be uniformly adopted for all patients, especially in women.
SCAI Survey Finds That Americans Are Avoiding Treatment for Heart Attack and Stroke Because of COVID-19 Risk
May 29, 2020—The Society for Cardiovascular Angiography and Interventions (SCAI) announced that findings from a newly released national survey confirm a growing concern among doctors and hospitals that people are more afraid of contracting COVID-19 by going to the hospital than seeking care for serious medical emergencies like heart attack or stroke.
SCAI Bestows Highest Designation on Leading Interventional Cardiologists
May 28, 2020—The Society for Cardiovascular Angiography and Interventions (SCAI) announced the presentation of its Master Interventionalists of SCAI (MSCAI) designations during the SCAI 2020 Scientific Sessions Virtual Conference MSCAI recognition ceremony on May 16.
SMT Enters Structural Heart Market With Acquisition of Vascular Concepts
May 28, 2020—Sahajanand Medical Technologies Pvt Ltd (SMT), a global medical device company based in India, announced its entry into the structural heart segment with the acquisition of Vascular Concepts, which is also headquartered in India.
TAVR Shown to Be Safe to Treat Bicuspid Valve Disease
May 27, 2020—The American College of Cardiology (ACC) announced the publication of a study demonstrating that transcatheter aortic valve replacement (TAVR) appears to be a safe treatment option with low complication rates for many patients with a bicuspid aortic valve that needs replacing.
COVID-19 Shown to Cause Severe Vascular Damage by Invading Endothelial Cells
May 21, 2020—The Angiogenesis Foundation announced the publication of new research showing that the respiratory virus SARS-CoV-2, which causes COVID-19, causes severe damage to blood vessels, leading to widespread thrombosis in the lung.
US Device Guide
This Device Guides offers a searchable, comprehensive listing of the available interventional cardiology devices in the United States.
European Device Guide
This Device Guides offers a searchable, comprehensive listing of the available interventional cardiology devices in Europe.
TAVR Trials Guide
A summary of the study data for all of the TAVR devices available in the United States market.
Most Read Articles
Sponsored by Penumbra, Inc.
Physician-Hospital Alignment Still Eludes Many Integrated Programs
Compensation and Production Trends for Interventionalists
Go Implant-Free in De Novo Lesions: DCB-Only Strategy
Limitations in Identifying and Managing HBR Patients Undergoing PCI
Single-Access Technique for Impella-Assisted High-Risk PCI
Innovation in Coronary Mechanical Thrombectomy: Indigo® System CAT™ RX Powered by Penumbra ENGINE™
Cerebral Protection During Structural Heart Interventions
Structural Valve Deterioration and Bioprosthetic Valve Failure